Parents of starved diabetic teen refused to accept diagnosis Video: A quick refresher on the role of glucose self-monitoring for patients Possible increased risk of leg and foot amputations with canagliflozin U.S. and European authorities issue safety announcement and continue to investigate. New diabetes treatment linked to red grapes and oranges Depression + metabolic risk factors boost chances of Type 2 diabetes Adding a DPP-4 inhibitor to sulfonylurea therapy increases hypoglycemia risk by 50% Sulfonylurea dose should be reduced when starting a DPP-4 inhibitor in type 2 diabetes. Updated Canadian diabetes guidelines for pharmacologic management of type 2 diabetes Empagliflozin should be added when glycemic targets are not met in patients with clinical cardiovascular disease. CE Lesson: Type 2 Diabetes Individualizing drug therapy in T2D. VIDEO: Gender-specific issues in diabetes A diabetes network for pharmacists First Previous 29 30 31 32 33 Next Last
